Filing Details
- Accession Number:
- 0000784199-25-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-10 17:18:53
- Reporting Period:
- 2025-03-06
- Filing Date:
- 2025-03-10
- Accepted Time:
- 2025-03-10 17:18:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Artivion Inc. | AORT | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408470 | P James Mackin | Artivion, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-06 | 115,701 | $0.00 | 878,107 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-03-06 | 17,739 | $24.80 | 860,368 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-03-06 | 75,615 | $21.55 | 935,983 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-06 | 70,700 | $24.76 | 865,283 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2025-03-06 | 75,615 | $0.00 | 75,615 | $21.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-12 | 2025-03-12 | No | 4 | M | Direct |
Footnotes
- Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date.
- These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024.
- Reflects weighted average price. Range of prices were between $24.40 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.
Billionaire Hedge Funds
